CommercialPrior AuthMedium impact
Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Blue Cross & Blue Shield of Mississippi·MS · Oncology, Hematology·Medical Policy
We identified it
Jun 20, 2026
Summary
Blue Cross Blue Shield of Mississippi updated their policy on hematopoietic cell transplantation for chronic lymphocytic leukemia and small lymphocytic lymphoma. The policy requires prior authorization through Case Management for all transplant procedures and evaluations, with allogeneic transplants considered medically necessary for poor-risk disease markers while autologous transplants remain investigational.
Action Required
Immediately: Billing team must ensure prior authorization is obtained through Case Management from Blue Cross & Blue Shield of Mississippi before scheduling any hematopoietic cell transplant procedures or evaluations for CLL/SLL patients. Update scheduling protocols to require Case Management approval before proceeding. Claims will be denied without proper prior authorization.